INTERSTITIAL LUNG DISEASE AND HEART MANIFESTATIONS ASSOCIATED WITH SYSTEMIC SCLEROSIS DURING RITUXIMAB TREATMENT

被引：0
|
作者：
Garzanova, Liudmila
Ananyeva, Lidia
Koneva, Olga A.
Ovsyannikova, Olga
Starovoytova, Mayya
Desinova, Oxana
Shayakhmetova, Rushana
Khelkovskaya-Sergeeva, Anna
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.2037
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3110A / 3111A
页数：2
相关论文
共 50 条
  • [1] RITUXIMAB FOR THE TREATMENT OF SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE: A CASE SERIES
    Ananyeva, L.
    Desinova, O.
    Starovoytova, M.
    Koneva, O.
    Yutkina, N.
    Onsyannikova, O.
    Volkov, A.
    Aleksandrova, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 648 - 648
  • [2] Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
    Mohammed, Abdel Gaffar A.
    Alshihre, Ammar
    Al-Homood, Ibrahim Abdulrazag
    ANNALS OF THORACIC MEDICINE, 2017, 12 (04) : 294 - 297
  • [3] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
    Hughes, Michael
    Denton, Christopher P.
    Khanna, Dinesh
    RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
  • [4] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Daoussis, Dimitrios
    Andonopoulos, Andrew P.
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (06) : 841 - 842
  • [5] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Dimitrios Daoussis
    Andrew P. Andonopoulos
    Rheumatology International, 2011, 31 : 841 - 842
  • [6] RESPONSE TO RITUXIMAB TREATMENT IN MALE AND FEMALE PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Ananyeva, Lidia
    Garzanova, Liudmila
    Koneva, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    Ovsyannikova, Olga
    Shayakhmetova, Rushana
    Khelkovskaya-Sergeeva, Anna
    Babak, Valeriya
    CHEST, 2024, 166 (04) : 6405A - 6405A
  • [7] Efficacy of Rituximab in Systemic Sclerosis with Interstitial Lung Disease
    Onat, Ahmet Mesut
    Zengin, Orhan
    Aksoy, Savas
    Onder, Mustafa Erkut
    Sacinti, Koray Gorkem
    Kisacik, Bunyamin
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Rituximab treatment for systemic sclerosis-associated interstitial lung disease: a case series of 13 patients
    Morgan, Kelly
    Woollard, Charlotte
    Beinart, Dylan
    Host, Lauren, V
    Roddy, Janet
    INTERNAL MEDICINE JOURNAL, 2023, 53 (07) : 1147 - 1153
  • [9] A BENEFICIAL EFFECT OF LONG-TERM TREATMENT OF RITUXIMAB IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Ananyeva, Lidia
    Koneva, Olga
    Garzanova, Liudmila
    Starovoytova, Mayya
    Desinova, Oxana
    Ovsyannikova, Olga
    Shayakhmetova, Rushana
    CHEST, 2022, 162 (04) : 2178A - 2178A
  • [10] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
12345